hepatitis
7 Must-Read Stories In February 2015
Ancient planets, ancient mammals and an exclusive interview with a not-so-ancient Nobel Prize winner with advice for young physicists in Asia!
Hot On The Trail Of The Hepatitis-Liver Cancer Connection
Infection with hepatitis viruses leads to the same genetic profile in tumors, even if they look different histologically.
BMS Foundation Awards US$3.5 Million In Hepatitis Grants
Bristol-Myers Squibb has awarded US$3.5 million in grants to tackle the 'silent epidemic' of hepatitis in India and China.
Neonatal HBV Vaccination Reduces Liver Cancer Risk
A follow-up study spanning 30 years shows that vaccinating babies against HBV reduces their risk of liver disease in adulthood.
HCV Genotype 1 Most Prevalent Worldwide
One third of the world's 83 million genotype 1 carriers reside in East Asia.
Gilead Allows India & China To Produce Generic HIV/HBV Drug
An agreement with the Medicines Patent Pool allows generics manufacturers in India and China to produce Gilead's HBV and HIV drug, tenofovir alafenamide.
Antivirals Reduce Liver Disease Risk
Two independent studies show that treating hepatitis B early with antiviral drugs can reduce the risk of developing liver disease.
Counting The Cost: Hepatitis C Treatment In Asia
How should decisions about the cost effectiveness of hepatitis C treatments be made? Rebecca Tan finds out what the experts think at the inaugural Singapore Hepatitis Conference held at Suntec Singapore Convention and Exhibition Center from 6-7 June 2014.
Agenix Sells HBV Drug To Cinkate For USD$2 Million
With the sale of its patented hepatitis drug AGX-1009 to Cintake, Agenix has exited all operations in China.
